Jaguar Health JAGX 深 沪
等待开盘 10-06 09:30:00 美东时间
4.73
+1.070
+29.23%
华盛通- 最 高41.53
- 今 开4.27
- 成交量 1016.87万股
- 最 低 0.1999
- 昨 收 3.66
- 总市值 36.83万
- 52周最高 84.00
- 市盈率 静 --
- 换手率 13059.58%
- 52周最低 0.1999
- 委 比 70.04%
- 总股本 7.79万
- 历史最高 87566062500.00
- 量 比 25.28
- 振 幅 1129.24%
- 历史最低 0.1999
- 每 手 1
- 风险率 23.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jaguar Health Stock Slides Thursday: What's Happening?
Jaguar Health is trading lower Thursday as investors weigh the clinical timeline for its rare pediatric disease pipeline after an update.
09-11 00:22
Jaguar Health shares are trading lower. The company announced its Napo unit provided crofelemer for treatment of congenital sodium diarrhea in an infant and said it plans to file for FDA approval for MVID in 2027.
Jaguar Health shares are trading lower. The company announced its Napo unit pro...
09-04 22:36
Jaguar Health Board Initiates Process To Mull, Review Strategic Options
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that its Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on
06-22 21:53
Jaguar Health CEO To Present At Life Sciences Virtual Investor Forum
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Wednesday, June 24, 2026 at the Life Sciences Virtual Investor Forum hosted by
06-12 21:03
Jaguar Health Announces One-Time Special Stock Dividend
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company") today announced that its Board of Directors has declared a one-time special stock dividend (the "Special Stock Dividend") to holders of Jaguar Common Stock
02-18 22:03
The Surge In Jaguar Health Stock: What's Happening Now?
Jaguar Health Inc (NASDAQ:JAGX) subsidiary, Napo Pharmaceuticals, has struck a new licensing deal with Woodward Specialty.
01-17 02:54
Jaguar Health Awarded $240K Grant From FAD's Center For Veterinary Medicine
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it received notice from the U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) on January 1, 2026 that the company has been awarded
01-02 22:04
Jaguar Health Awarded Patent in Jordan for Short Bowel Syndrome Treatment
10:58 AM EDT, 08/27/2024 (MT Newswires) -- Jaguar Health (JAGX) said Tuesday its Napo Pharmaceuticals unit received a patent in Jordan for its crofelemer antidiarrheal drug. The patent covers methods for treating short bowel syndrome, bile acid diarrhea, and diarrhea associated with small intestine ...
2024-08-27 22:58
Jaguar Health Reports Issue of Hong Kong Patent for Short Bowel Syndrome Treatment Methods
11:29 AM EDT, 08/19/2024 (MT Newswires) -- Jaguar Health (JAGX) said Monday Hong Kong's Intellectual Property Department has issued a new patent to its family firm, Napo Pharmaceuticals, for methods for treating short bowel syndrome, bile acid diarrhea, and diarrhea associated with small intestine r...
2024-08-19 23:29
